(Journal Article): Proteomic Identification and Immunolocalization of Increased Renal Calbindin-D28k Expression in OVE26 Diabetic Mice
 
Thongboonkerd V, Zheng S, McLeish KR, Epstein PN, Klein JB (Core Proteomics Laboratory, Kidney Disease Program, Department of Medicine, University of Louisville, Louisville, KY, USA, thongboonkerd(at)dr.com )
 
IN: Rev Diabetic Stud 2005; 2(1):19-26
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

Fulltext:    HTML  PDF

ABSTRACT: Diabetic nephropathy is a common diabetic complication that is associated with alterations in the expression of several renal proteins and abnormal calcium homeostasis. We performed proteomic analysis to screen for global changes of renal protein expression in diabetic kidney. Proteins extracted from the whole kidney of 120-day-old OVE26 (a transgenic model of Type 1 diabetes) and FVB (non-diabetic background strain) mice were separated by two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) and visualized by SYPRO Ruby staining (n = 5 in each group). Quantitative intensity analysis revealed 41 differentially expressed proteins, of which 30 were identified by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) followed by peptide mass fingerprinting. One of the altered proteins with the greatest magnitude of change was the calcium-binding protein, calbindin-D28k, whose expression was increased 6.7-fold in diabetic kidney. We confirmed the increase in calbindin-D28k expression in diabetic kidney by Western blot analysis. Immunohistochemical study demonstrated that calbindin-D28k expression was markedly increased in tubular epithelial cells of distal convoluted tubules (DCT), collecting ducts (CD), and proximal convoluted tubules (PCT) in diabetic kidney. Calbindin-D28k plays a critical role in maintaining calcium homeostasis. The elevation in renal calbindin-D28k expression in our model may indicate a compensatory mechanism to overcome hypercalciuria in diabetes.

TYPE OF PUBLICATION: Original article

REFERENCES:

1. USRDS. Incidence and prevalence of ESRD. United States Renal Data System. Am J Kidney Dis 1997. 30:S40-S53. [DOD]
2. Schleicher E, Kolm V, Ceol M, Nerlich A. Structural and functional changes in diabetic glomerulopathy. Kidney Blood Press Res 1996. 19:305-315. [DOD]
3. Mauer SM, Lane P, Hattori M, Fioretto P, Steffes MW. Renal structure and function in insulin-dependent diabetes mellitus and type I membranoproliferative glomerulonephritis in humans. J Am Soc Nephrol 1992. 2:S181-S184. [DOD]
4. Chau DL, Edelman SV, Chandran M. Osteoporosis and diabetes. Curr Diab Rep 2003. 3:37-42. [DOD]
5. Selby PL. Osteopenia and diabetes. Diabet Med 1988. 5:423-428. [DOD]
6. Malone JI, Lowitt S, Duncan JA, Shah SC, Vargas A, Root AW. Hypercalciuria, hyperphosphaturia, and growth retardation in children with diabetes mellitus. Pediatrics 1986. 78:298-304. [DOD]
7. Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 1990. 39:477-482. [DOD]
8. Stone LA, Weaver VM, Bruns ME, Christakos S, Welsh J. Vitamin D receptors and compensatory tissue growth in spontaneously diabetic BB rats. Ann Nutr Metab 1991. 35:196-202. [DOD]
9. Ward DT, Yau SK, Mee AP, Mawer EB, Miller CA, Garland HO, Riccardi D. Functional, molecular, and biochemical characterization of streptozotocin-induced diabetes. J Am Soc Nephrol 2001. 12:779-790. [DOD]
10. Kayath MJ, Dib SA, Vieiaa JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications 1994. 8:97-104. [DOD]
11. Carlson EC, Audette JL, Klevay LM, Nguyen H, Epstein PN. Ultrastructural and functional analyses of nephropathy in calmodulin- induced diabetic transgenic mice. Anat Rec 1997. 247:9-19. [DOD]
12. Epstein PN, Overbeek PA, Means AR. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 1989. 58:1067-1073. [DOD]
13. Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN. Development of Late-Stage Diabetic Nephropathy in OVE26 Diabetic Mice. Diabetes 2004. 53:3248-3257. [DOD]
14. Thongboonkerd V, Barati MT, McLeish KR, Benarafa C, Remold-O'Donnell E, Zheng S, Rovin BH, Pierce WM, Epstein PN, Klein JB. Alterations in the renal elastin-elastase system in Type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol 2004. 15:650-662. [DOD]
15. Thongboonkerd V, Gozal E, Sachleben LR, Arthur JM, Pierce WM, Cai J, Chao J, Bader M, Pesquero JB, Gozal D et al. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. J Biol Chem 2002. 277:34708-34716. [DOD]
16. Arthur JM, Thongboonkerd V, Scherzer JA, Cai J, Pierce WM, Klein JB. Differential expression of proteins in renal cortex and medulla: a proteomic approach. Kidney Int 2002. 62:1314-1321. [DOD]
17. Berry KJ, Mielke PW, Jr. Exact and Monte Carlo resampling procedures for the Wilcoxon-Mann-Whitney and Kruskal-Wallis tests. Percept Mot Skills 2000. 91:749-754. [DOD]
18. Thongboonkerd V, Luengpailin J, Cao J, Pierce WM, Cai J, Klein JB, Doyle RJ. Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors. J Biol Chem 2002. 277:16599-16605. [DOD]
19. Thongboonkerd V, Klein JB, Pierce WM, Jevans AW, Arthur JM. Sodium loading changes urinary excretion: A proteomic analysis. Am J Physiol Renal Physiol 2003. 284:F1155-F1163. [DOD]
20. Thongboonkerd V, Klein JB, Arthur JM. Proteomic identification of a large complement of rat urinary proteins. Nephron Exp Nephrol 2003. 95:e69-e78. [DOD]
21. Gozal E, Gozal D, Pierce WM, Thongboonkerd V, Scherzer JA, Sachleben LR, Zhang-Z G, Cai J, Klein JB. Proteomic analysis of CA1 and CA3 regions of rat hippocampus and differential susceptibility to intermittent hypoxia. J Neurochem 2002. 83:331-345. [DOD]
22. Sooy K, Kohut J, Christakos S. The role of calbindin and 1,25dihydroxyvitamin D3 in the kidney. Curr Opin Nephrol Hypertens 2000. 9:341-347. [DOD]
23. Borke JL, Caride A, Verma AK, Penniston JT, Kumar R. Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules. Am J Physiol 1989. 257:F842-F849. [DOD]
24. Biner HL, Arpin-Bott MP, Loffing J, Wang X, Knepper M, Hebert SC, Kaissling B. Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol 2002. 13:836-847. [DOD]
25. Hoenderop JG, Hartog A, Stuiver M, Doucet A, Willems PH, Bindels RJ. Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine. J Am Soc Nephrol 2000. 11:1171-1178. [DOD]
26. Hoenderop JG, Nilius B, Bindels RJ. Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol 2002. 64:529-549. [DOD]
27. Christakos S, Gabrielides C, Rhoten WB. Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. Endocr Rev 1989. 10:3-26. [DOD]
28. Koster HP, Hartog A, van Os CH, Bindels RJ. Calbindin-D28K facilitates cytosolic calcium diffusion without interfering with calcium signaling. Cell Calcium 1995. 18:187-196. [DOD]
29. Yang CW, Kim J, Kim YH, Cha JH, Mim SY, Kim YO, Shin YS, Kim YS, Bang BK. Inhibition of calbindin-D28K expression by cyclosporin A in rat kidney: the possible pathogenesis of cyclosporin A-induced hypercalciuria. J Am Soc Nephrol 1998. 9:1416-1426. [DOD]
30. Grenet O, Bobadilla M, Chibout SD, Steiner S. Evidence for the impairment of the vitamin D activation pathway by cyclosporine A. Biochem Pharmacol 2000. 59:267-272. [DOD]
31. Grenet O, Varela MC, Staedtler F, Steiner S. The cyclosporine A-induced decrease in rat renal calbindin-D28kDa protein as a consequence of a decrease in its mRNA. Biochem Pharmacol 1998. 55:1131-1133. [DOD]
32. Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, Steiner S. Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization. Biochem Pharmacol 1997. 53:723-731. [DOD]
33. Zheng W, Xie Y, Li G, Kong J, Feng JQ, Li YC. Critical role of calbindin-D28k in calcium homeostasis revealed by mice lacking both vitamin D receptor and calbindin-D28k. J Biol Chem 2004. 279:52406-52413. [DOD]
34. Anwana AB, Garland HO. Renal calcium and magnesium handling in experimental diabetes mellitus in the rat. Acta Endocrinol (Copenh) 1990. 122:479-486. [DOD]
35. Wu MJ, Lai LW, Lien YH. Cytoprotective effects of calbindin-D(28k) against antimycin-A induced hypoxic injury in proximal tubular cells. Life Sci 2002. 71:559-569. [DOD]
36. Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S. Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 2001. 142:3649-3655. [DOD]
37. Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X. Vitamin D target proteins: function and regulation. J Cell Biochem 2003. 88:238-244. [DOD]
38. Chard PS, Bleakman D, Christakos S, Fullmer CS, Miller RJ. Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones. J Physiol 1993. 472:341-357. [DOD]
39. Guo Q, Sopher BL, Furukawa K, Pham DG, Robinson N, Martin GM, Mattson MP. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 1997. 17:4212-4222. [DOD]
40. Hamilton K, Tein M, Glazier J, Mawer EB, Berry JL, Balment RJ, Boyd RD, Garland HO, Sibley CP. Altered calbindin mRNA expression and calcium regulating hormones in rat diabetic pregnancy. J Endocrinol 2000. 164:67-76. [DOD]